AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+1.16%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.73B
AUM Growth
+$1.73B
Cap. Flow
+$946K
Cap. Flow %
0.05%
Top 10 Hldgs %
45.72%
Holding
140
New
9
Increased
17
Reduced
13
Closed
14

Top Buys

1
AGEN
Agenus
AGEN
$25.2M
2
RVMD icon
Revolution Medicines
RVMD
$23.8M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$23M
4
VOR icon
Vor Biopharma
VOR
$15.5M
5
KYMR icon
Kymera Therapeutics
KYMR
$12.5M

Top Sells

1
ARGX icon
argenx
ARGX
$53M
2
SGEN
Seagen Inc. Common Stock
SGEN
$47.9M
3
BLU
BELLUS Health Inc.
BLU
$18.9M
4
SLDB icon
Solid Biosciences
SLDB
$11.2M
5
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$11M

Sector Composition

1 Healthcare 95.14%
2 Consumer Discretionary 3.86%
3 Real Estate 0.4%
4 Financials 0.24%
5 Industrials 0.19%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LXRX icon
1
Lexicon Pharmaceuticals
LXRX
$400M
$171M 9.57% 89,778,234 – –
ONC
2
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$132M 7.37% 600,000 -50,000 -8% -$11M
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$83M 4.64% 1,832,758 +507,758 +38% +$23M
SRRK icon
4
Scholar Rock
SRRK
$3.14B
$81.3M 4.54% 8,980,270 +230,236 +3% +$2.08M
CERE
5
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$59.9M 3.34% 1,900,000 -100,000 -5% -$3.15M
MORF
6
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$57.5M 3.21% 2,150,000 – –
WW
7
DELISTED
WW International
WW
$57.2M 3.19% 14,818,300 – –
SWTX
8
DELISTED
SpringWorks Therapeutics
SWTX
$52M 2.9% 2,000,000 -53,403 -3% -$1.39M
KYMR icon
9
Kymera Therapeutics
KYMR
$2.95B
$49.9M 2.79% 2,000,000 +500,000 +33% +$12.5M
FOLD icon
10
Amicus Therapeutics
FOLD
$2.34B
$48.8M 2.73% 4,000,000 – –
APLS icon
11
Apellis Pharmaceuticals
APLS
$3.48B
$46.5M 2.6% 900,000 -100,000 -10% -$5.17M
CYTK icon
12
Cytokinetics
CYTK
$4.23B
$45.8M 2.56% 1,000,000 – –
IGMS
13
DELISTED
IGM Biosciences
IGMS
$41.7M 2.33% 2,450,000 – –
AGEN
14
Agenus
AGEN
$133M
$34.8M 1.94% 14,500,000 +10,500,000 +263% +$25.2M
KRYS icon
15
Krystal Biotech
KRYS
$4.27B
$31.7M 1.77% 400,000 -100,000 -20% -$7.92M
BLU
16
DELISTED
BELLUS Health Inc.
BLU
$30.4M 1.7% 3,700,000 -2,300,000 -38% -$18.9M
KRTX
17
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$29.5M 1.65% 150,000 +25,000 +20% +$4.91M
KLRS
18
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
$28.6M 1.6% 5,577,167 – –
SAGE
19
DELISTED
Sage Therapeutics
SAGE
$28.6M 1.6% 750,000 – –
VIGL
20
DELISTED
Vigil Neuroscience
VIGL
$28M 1.57% 2,243,352 -42,222 -2% -$528K
SEER icon
21
Seer Inc
SEER
$115M
$27.6M 1.54% 4,750,000 – –
FATE icon
22
Fate Therapeutics
FATE
$120M
$26.2M 1.46% 2,600,000 – –
RVMD icon
23
Revolution Medicines
RVMD
$7.1B
$23.8M 1.33% +1,000,000 New +$23.8M
DNLI icon
24
Denali Therapeutics
DNLI
$2.23B
$22.2M 1.24% 800,000 +200,000 +33% +$5.56M
RLAY icon
25
Relay Therapeutics
RLAY
$619M
$21.7M 1.21% 1,454,716 – –
1
2 3 4 5